XORTX Therapeutics (XRTX) news
Recent news
Xortx Therapeutics - Expects voluntary dellisting from TSXV to take effect September 1, 226
AInvest Wire · 3d agoXortx announces termination and postponement of investor relations program
AInvest Wire · 3d agoXortx announces director resignation
XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU) has announced resignation of a director , effective July 27, 2026. The company has appointed Depesh Narotam as an independent director to fill the vacancy. Mr. Narotam brings over 20 years of experience in the financial services…
AInvest Wire · Jul 31, 2026XORTX Therapeutics' shares jumped 9% Wednesday after the Canadian pharmaceutical company submitted a new patent for the treatment of chronic kidney disease
XORTX Therapeutics' shares jumped 9% Wednesday after the Canadian pharmaceutical company submitted a new patent for the treatment of chronic kidney disease XORTX Therapeutics, a Canadian pharmaceutical company, recently submitted a new patent for the treatment of chronic kidney disease (CKD). The…
AInvest Wire · Jan 3, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.